<DOC>
	<DOCNO>NCT00686751</DOCNO>
	<brief_summary>The purpose study examine whether vitamin D reduce activation immune system dialysis . When activate , immune cell release certain substance , call cytokine , measure small blood sample . We want study degree immune system activate regular dialysis treatment whether time point vitamin D administration , either right start right end dialysis treatment , impact activation immune system .</brief_summary>
	<brief_title>Immune Effects Vitamin D Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>Patient stable chronic hemodialysis 3 month . PTH level 150 800 pg/ml . Ability give inform consent . Serum calcium level ( correct albumin level 4.0 g/dL ) less 10.5 mg/dL last three consecutive measurement . Serum Phosphorus level 2.5 7.0 mg/dL last three consecutive measurement . Ca x PProduct le 75 mg2/dL2 last three consecutive measurement . Known active malignancy . Liver disease define serum aspartate aminotransferase , alanine aminotransferase , gammaglutamyltransferase level 2 time upper limit normal . PTH level 150 pg/mL 800 pg/mL . Hypercalcemia hypercalcemic episode within last 4 week . Ca x PProduct 75 mg2/dL2 within last 4 week . Any clinical significant infection treat antibiotic within 6 week prior start study . Chronic viral infection ( HIV , Hepatitis B C ) . Currently immunosuppressive medication ( steroid , cyclosporine , etcâ€¦ ) . Hematocrit le 30 % . History blood disorder renal anemia . Age le 18 year 75 year . Hypersensitivity paricalcitol ingredient product . Parathyroidectomy . Participation another study time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>